New research (the Ver-A-T1D trial) presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...
New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...
UAB diabetes researchers presented their latest work on an international stage at the 61 st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria, Sept. 15-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback